Esophageal Dysphagia Market Research Report – Forecast to 2027

Esophageal Dysphagia Market Research Report, by Diagnosis (X-Ray, Endoscopy, and Imaging Tests), Treatment (Esophageal Dilation), Products (Feeding Tube), & End-User (Hospitals and Clinics & Ambulatory Surgical Centers) -Forecast Till 2027

Esophageal Dysphagia Market Scenario


Dysphagia is a problem related to swallowing liquid or solid food. Esophageal dysphagia (ED) is a food pipe related problem, occurs when there is a swallowing problem in the esophagus. Esophageal dysphagia can be caused due to foreign bodies, esophageal tumors, esophageal stricture, caustic esophagitis, eosinophilic esophagitis, achalasia, and scleroderma. The key factor responsible for influencing this market is the increasing prevalence of increase in aging, cancer, radiation therapy and cardiovascular or respiratory such as stroke and other.


 Other key factors such as a change to sedentary lifestyle, or a side effect of some medications, increasing in smoking are contributing to the growth of the market. According to the World Health Organization in 2015, globally 1.1 billion people smoked tobacco. This is expected to provide favorable backgrounds for market growth during the forecast period. However, factors such as, expensive surgery treatments, the high cost of surgical procedures and side effects associated with medication are expected to restrict the market growth during the forecast period.


Segmentation


The esophageal dysphagia market is segmented on the basis of diagnosis, treatment, products, and end-user. The esophageal dysphagia market, by diagnosis, is categorized into X-ray, dynamic swallowing study, endoscopy, manometry, and imaging scans. Imaging scans are sub-segmented into MRI scan, CT scan. On the basis of treatment, the market is segmented into esophageal dilation, surgery, medications, lifestyle changes. Surgery is sub-segmented into stent placement and laparoscopic heller myotomy. On the basis of products, the market is segmented into the feeding tube, nutritional solutions, and drugs. A feeding tube is sub-segmented into the nasogastric tube, percutaneous endoscopic gastrostomy. Nutritional solutions are sub-segmented into thickeners, beverages, and purees. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, research centers, and others. On the basis of region, the esophageal dysphagia market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.


Key players


Some of the key players in the esophageal dysphagia market are Merck Sharp & Dohme Corp., Biostagel, Torax Medical Inc., Nine Point Medical Inc., Elekta AB, Eisai Co Ltd, Cipla Ltd., AstraZeneca Plc, Kent Precision Foods Group, Inc., Nestlé Health Science France, Nutricia Ltd, C.R.Bard, Inc., Cook Medical Incorporated and others.


Regional Market Summary


It is estimated that North America dominated the esophageal dysphagia market owing to the increasing innovations in clinical practice, growing geriatric population and increasing incidences of oral cancer in this region cancer research, and access to cancer treatment in this region.


According, to the International Association of Logopedics and phoniatrics 2018, the report estimated 29% to 64% of stroke patients can occur dysphagia globally. According to the Centers for Disease Control and Prevention in September 2017, 795,000 people the US have a stroke every year. Such a high prevalence of stroke in the US influences the market growth.


Europe stood second largest in the esophageal dysphagia market owing to the increasing use of tobacco. According to the World Health Organizations’ Fact Sheet on Tobacco and Oral Health (2018), Europe has the highest prevalence of tobacco smoking among adults that is 28% of adults in Europe are engaged in smoking. Such a high prevalence of smoking in this region facilitates the market growth in this region.


Asia-Pacific was projected to be the fastest growing region for the esophageal dysphagia market in 2017. The market is expected to witness growth owing to the rising prevalence of oral cancer, increasing tobacco, changing lifestyle, and certain immune system disorders. The Center for Cancer Control and Information Services has estimated 15,600 cases of pharynx cancer and oral cavity in 2017 in this region. Such a high incidence of oral cancer favors the market growth.


The Middle East and Africa holds the least share in the esophageal dysphagia market due to the presence of poor health expenditure and low per capita income. However, the market is expected to witness growth due to increasing awareness programs in the Middle East.


Intended Audience



  • Pharmaceutical companies

  • Biotechnological institutes

  • Government and private laboratories

  • Research and Development (R&D) companies

  • Medical research laboratories

  • Market research and consulting service providers


Market Segmentation and Key Market Players


Some of the key players in the esophageal dysphagia market are Merck Sharp & Dohme Corp., Biostagel, Torax Medical, Inc., NinePoint Medical, Inc., Elekta AB, Eisai Co Ltd, Cipla Ltd., AstraZeneca Plc, Kent Precision Foods Group, Inc., Nestlé Health Science France, Nutricia Ltd, C.R. Bard, Inc., Cook Medical Incorporated, and others. 


Esophageal Dysphagia Market, by Diagnosis



  • X-ray

  • Dynamic swallowing study

  • Endoscopy

  • Manometry

  • Imaging scans

  • MRI scan

  • CT scan


Esophageal Dysphagia Market, by Treatment



  • Esophageal dilation

  • Surgery

  • Stent placement

  • Laparoscopic Heller myotomy

  • Medications

  • Lifestyle changes

  •  


Esophageal Dysphagia Market, by Products



  • Feeding Tube

  • Nasogastric Tube

  • Percutaneous Endoscopic Gastrostomy

  • Nutritional Solutions

  • Thickeners

  • Beverages

  • Purees

  • Drugs

  • Proton Pump Inhibitors

  • Other


Esophageal Dysphagia Market, by End-Users



  • Hospitals and clinics

  • Ambulatory surgical centers

  • Diagnostic centers

  • Research centers

  • Others


Esophageal Dysphagia Market, by Region



  • Americas

  • Europe

  • Asia-Pacific

  • Middle East & Africa



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   2020-2027: Substantial CAGR
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Basis of diagnosis, Treatment, Products, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Merck Sharp & Dohme Corp., Biostagel, Torax Medical Inc., Nine Point Medical Inc., Elekta AB, Eisai Co Ltd, Cipla Ltd., AstraZeneca Plc, Kent Precision Foods Group, Inc., Nestlé Health Science France, Nutricia Ltd, C.R.Bard, Inc., Cook Medical Incorporated and others.
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Change to sedentary lifestyle
  • A side effect of some medications
  • Increasing in smoking


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Esophageal dysphagia market would be spurred by radiation therapies and cardiovascular diseases like stroke and others.

    Esophageal dysphagia market growth could be hindered by the high cost of surgeries, side effects, and others.

    The segments are dynamic swallowing study, X-ray, manometry, endoscopy, and imaging scans.

    The segments are surgery, medications, esophageal dilation, and lifestyle changes.

    The end users are ambulatory surgical centers, hospitals & clinics, research centers, diagnostic centers, and others.